Mankind Pharma Expands Diabetes Portfolio Through Exclusive Insulin Licensing Agreement MM Desk 22 August, 2026 Mankind Pharma Limited (BSE: 543904 | NSE: MANKIND), one of India’s leading pharmaceutical companies, has Read More
Mankind Pharma Introduces PetStar Delight to Enter the Cat Food Category MM Desk 5 December, 2025 Mankind Pharma has broadened its presence in the pet nutrition space with the launch of Read More
Mankind Pharma Board to Review Fundraising Options MM Desk 19 September, 2024 Mankind Pharma announced on Tuesday that its board of directors is scheduled to convene later Read More
Mankind Pharma open to acquisitions MM Desk 17 May, 2024 Mankind Pharma, has announced its openness to acquisitions, following an impressive 65% increase in profit Read More